terms |
ibalizumab |
As nouns the difference between terms and ibalizumab
is that
terms is while
ibalizumab is a nonimmunosuppressive monoclonal antibody being investigated as an hiv entry inhibitor.
inhibitor |
ibalizumab |
As nouns the difference between inhibitor and ibalizumab
is that
inhibitor is any substance capable of stopping or slowing a specific chemical reaction while
ibalizumab is a nonimmunosuppressive monoclonal antibody being investigated as an HIV entry inhibitor.
entry |
ibalizumab |
As nouns the difference between entry and ibalizumab
is that
entry is (uncountable) the act of entering while
ibalizumab is a nonimmunosuppressive monoclonal antibody being investigated as an hiv entry inhibitor.
hiv |
ibalizumab |
As nouns the difference between hiv and ibalizumab
is that
hiv is initialism of human immunodeficiency virus while
ibalizumab is a nonimmunosuppressive monoclonal antibody being investigated as an HIV entry inhibitor.
nonimmunosuppressive |
ibalizumab |
As an adjective nonimmunosuppressive
is not immunosuppressive.
As a noun ibalizumab is
a nonimmunosuppressive monoclonal antibody being investigated as an hiv entry inhibitor.